当前位置:
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply.
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2019-03-01 , DOI: 10.1111/apt.15155 Kin Seng Liem 1, 2 , Harry L A Janssen 1
中文翻译:
社论:鉴定HBeAg阳性慢性乙型肝炎患者恩替卡韦治疗的聚乙二醇化干扰素附加药物的候选人-作者的答复。
更新日期:2019-11-01
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2019-03-01 , DOI: 10.1111/apt.15155 Kin Seng Liem 1, 2 , Harry L A Janssen 1
Affiliation
中文翻译:
社论:鉴定HBeAg阳性慢性乙型肝炎患者恩替卡韦治疗的聚乙二醇化干扰素附加药物的候选人-作者的答复。